CN112098527A
|
|
Detection method of ticagrelor starting material
|
CN112028794A
|
|
High-purity kaglutamic acid and preparation method thereof
|
CN111718297A
|
|
Eltrombopag diethanolamine salt and preparation method thereof
|
CN111323497A
|
|
Optical purity analysis method of pasireotide starting material
|
CN111272944A
|
|
Method for analyzing and separating timolol and optical isomer thereof
|
CN111235212A
|
|
Method for checking and determining microbial limit of moxifloxacin hydrochloride raw material medicine
|
CN111233887A
|
|
Synthesis process of dorzolamide hydrochloride intermediate
|
CN111214437A
|
|
Azithromycin microemulsion gel and preparation method and application thereof
|
CN111122557A
|
|
Method for measuring azo diisobutyronitrile free radical initiation efficiency
|
CN111084758A
|
|
Dorzolamide hydrochloride eye drops and preparation method thereof
|
CN111087315A
|
|
Synthetic method of eltrombopag intermediate and synthetic method of eltrombopag
|
CN111089821A
|
|
Dissolution rate determination method and application of eltrombopag tablets
|
CN110954647A
|
|
Sample treatment method for measuring total nitrogen content in polyvinyl alcohol and method for measuring total nitrogen content in polyvinyl alcohol
|
CN110903299A
|
|
Method for refining dorzolamide hydrochloride
|
CN110787126A
|
|
Moxifloxacin hydrochloride ophthalmic gel and preparation method thereof
|
CN110711180A
|
|
Ticagrelor composition and preparation method thereof
|
CN110713440A
|
|
Preparation method of vigabatrin
|
CN110627874A
|
|
Preparation method of pasireotide
|
CN110590975A
|
|
Medicinal polyvinyl alcohol and preparation method thereof
|
CN108409735A
|
|
A kind of purification process of moxifloxacin hydrochloride and the preparation method of moxifloxacin hydrochloride
|